Quantitation of In Vitro α-1 Adrenergic Receptor Antagonist Binding Capacity to Biologic Melanin Using Tandem Mass Spectrometry. (December 2013)
- Record Type:
- Journal Article
- Title:
- Quantitation of In Vitro α-1 Adrenergic Receptor Antagonist Binding Capacity to Biologic Melanin Using Tandem Mass Spectrometry. (December 2013)
- Main Title:
- Quantitation of In Vitro α-1 Adrenergic Receptor Antagonist Binding Capacity to Biologic Melanin Using Tandem Mass Spectrometry
- Authors:
- Gaynes, Jeffrey S.
Micic, Cedomir
Gaynes, Bruce I.
Borgia, Jeffrey A. - Abstract:
- <abstract> <title>Abstract</title> <p> <italic>Purpose</italic>: The purpose of this study was to develop methods to allow evaluation of the binding characteristics for a series of α-1 antagonists to biologically-derived melanin.</p> <p> <italic>Methods</italic>: Fresh bovine globes were used to obtain iridal and choroid/retinal pigment epithelial (CRPE) derived melanin. Binding characteristics of chloroquine, tamsulosin and doxazosin were then evaluated <italic>in vitro</italic> using tandem mass spectroscopy.</p> <p> <italic>Results</italic>: Tandem mass spectrometry-based assays were developed for three α-1 antagonists that provided linear assay ranges which spanned (minimally) 0.01–10 µg/mL, while exhibiting excellent inter-assay precision and accuracy. When applied to the evaluation of binding characteristics for iridal melanin, mean chloroquine and tamsulosin fractions were found to be 41.9 ± 14.2 pmoles mg<sup>−1</sup> and 25.34 ± 6.186 pmoles mg<sup>−1</sup>, respectively. Mean iridal doxazosin binding was found to be 6.36 ± 2.19 pmoles mg<sup>−1</sup>. Interestingly, mean levels of tamsulosin, but not doxazosin found bound to choroid/CRPE derived melanin approached that of chloroquine (27.91 µg/mL, 25.68 µg/mL and 5.94 µg/mL for chloroquine, tamsulosin and doxazosin, respectively). One way ANOVA for binding affinity for chloroquine, tamsulosin and doxazosin was statistically significant for both iridal and CRPE-derived melanin (<italic>p</italic> = 0.0012 and<abstract> <title>Abstract</title> <p> <italic>Purpose</italic>: The purpose of this study was to develop methods to allow evaluation of the binding characteristics for a series of α-1 antagonists to biologically-derived melanin.</p> <p> <italic>Methods</italic>: Fresh bovine globes were used to obtain iridal and choroid/retinal pigment epithelial (CRPE) derived melanin. Binding characteristics of chloroquine, tamsulosin and doxazosin were then evaluated <italic>in vitro</italic> using tandem mass spectroscopy.</p> <p> <italic>Results</italic>: Tandem mass spectrometry-based assays were developed for three α-1 antagonists that provided linear assay ranges which spanned (minimally) 0.01–10 µg/mL, while exhibiting excellent inter-assay precision and accuracy. When applied to the evaluation of binding characteristics for iridal melanin, mean chloroquine and tamsulosin fractions were found to be 41.9 ± 14.2 pmoles mg<sup>−1</sup> and 25.34 ± 6.186 pmoles mg<sup>−1</sup>, respectively. Mean iridal doxazosin binding was found to be 6.36 ± 2.19 pmoles mg<sup>−1</sup>. Interestingly, mean levels of tamsulosin, but not doxazosin found bound to choroid/CRPE derived melanin approached that of chloroquine (27.91 µg/mL, 25.68 µg/mL and 5.94 µg/mL for chloroquine, tamsulosin and doxazosin, respectively). One way ANOVA for binding affinity for chloroquine, tamsulosin and doxazosin was statistically significant for both iridal and CRPE-derived melanin (<italic>p</italic> = 0.0012 and 0.0023), respectively. A Bonferroni <italic>post-hoc</italic> analysis demonstrated a statistically significant difference in the amount of binding between tamsulosin, doxazosin and chloroquine to iridal but not CRPE derived melanin (<italic>p</italic> &lt; 0.05).</p> <p> <italic>Conclusions</italic>: Tamsulosin appears to demonstrate melanin binding affinity which approaches chloroquine and exceeds doxazosin for both iridal and CRPE-derived bovine melanin.</p> </abstract> … (more)
- Is Part Of:
- Current eye research. Volume 38:Number 12(2013:Dec.)
- Journal:
- Current eye research
- Issue:
- Volume 38:Number 12(2013:Dec.)
- Issue Display:
- Volume 38, Issue 12 (2013)
- Year:
- 2013
- Volume:
- 38
- Issue:
- 12
- Issue Sort Value:
- 2013-0038-0012-0000
- Page Start:
- 1214
- Page End:
- 1220
- Publication Date:
- 2013-12
- Subjects:
- Ophthalmology -- Periodicals
Eye -- Diseases -- Periodicals
Ophthalmology -- Periodicals
573.88 - Journal URLs:
- http://informahealthcare.com/journal/cey ↗
http://www.tandfonline.com/toc/icey20/current ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/02713683.2013.822894 ↗
- Languages:
- English
- ISSNs:
- 0271-3683
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3496.570000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3012.xml